ShangPharma Corp

Private Company Ticker Symbol™: (ANGARMP)

What's included with your PrivCo Report Purchase:

Next Actions on ShangPharma Corp:

Business Summary

ShangPharma Corp is a privately-held company that operates in the Biochemicals industry. ShangPharma Corp headquarters are located in Shanghai, China.

Overview & Corporate Organization

Basic Information

Company Tags:	PE Backed
Fiscal Year End:	12/31
1YR Revenue Growth Rate:	View %
3YR Revenue Growth Rate (CAGR):	View %
City:	Shanghai
Country:	China
Website:	www.shangpharma.com

Industry Information

Industry Codes

PICS™:	1000303™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Manufacturing & Industrial > Chemical Manufacturing > Biochemicals

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Ownership

PrivCo's Ownership table displays who owns ShangPharma Corp, including owner name, each type of owner (whether family, individual, private equity firm, etc.)

Owner Name	Type of Owner	% Ownership Stake
View	View	View

Charts, Financials, and Statistics (Table Format)

Below are ShangPharma Corp financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All ShangPharma Corp Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2011	2010	2009	2008	2007
Revenues	View	View	View	View	View
COR-Unrelated Parties	View	View	View	View	View
COR-Related Parties	View	View	View	View	View
Selling & Marketing	View	View	View	View	View
General & Administrative	View	View	View	View	View
Other Operating Income	View
Other Operating Expenses	View
Total Operating Expense	View	View	View	View	View
Interest expense	View	View
Interest Income	View	View	View	View	View
Other Income	View	View	View	View	View
Other Expenses	View	View	View	View	View
Net Income Before Taxes	View	View	View	View	View
Provision for Income Taxes	View	View	View	View	View
Net Income (Loss)	View	View	View	View	View

Balance Sheet	2011	2010	2009	2008
Cash and cash equivalents	View	View	View	View
Restricted cash	View	View	View	View
Investment in securities			View
Accounts Receivables	View	View	View	View
Allowance for Doubtful Accounts	View	View	View	View
Amount Due from Related Parties	View
Raw Materials	View	View	View	View
Work in Progress	View	View	View	View
Finished Goods	View	View	View	View
Prepaid Rental & Deposit	View	View	View	View
Deposit to be Refunded for Purchase LR	View		View	View
Prepayments for Purchase of RM	View	View	View	View
Prepayment for D&O insurance	View	View
Derivative assets	View	View
Receivables for transferring parts	View
Interest receivable	View
Others	View	View	View	View
Deferred Tax Assets	View	View	View	View
Total Current Assets	View	View	View	View
Investment in Securities				View
Leasehold Improvements	View	View	View	View
Experimental Equipment	View	View	View	View
Vehicles	View	View	View	View
Office Equipment & Others	View	View	View	View
Buildings and constructions	View	View
Software Licenses	View	View	View	View
Construction in Progress	View	View	View	View
Accumulated Depreciation & Amortization	View	View	View	View
Derivative assets	View	View
Land Use Right	View	View	View
Accumulated amortization	View	View	View
Amounts due from related parties	View
Other long-term assets	View	View
Deferred Tax Assets	View
Total Assets	View	View	View	View
Short-term bank borrowings		View
Accounts Payable	View	View	View	View
Amounts Due to Related Parties	View	View	View	View
Salary & Welfare Payable	View	View	View	View
Income Taxes Payable	View	View	View	View
Advance from Customers	View	View	View	View
Value Added Tax & Other Taxes Payable	View	View	View	View
Accrued Rental & Utilities	View	View	View	View
Derivative Liability	View	View	View	View
Accrued Consulting & Audit Fee	View	View	View	View
Unearned Government Subsidies	View	View	View	View
Accrued Employee Annual Leave	View	View	View	View
Accrued IPO bonuses and other employee income		View
Accrued lab partner service fees	View
Provision for loss contract accruals	View
Government incentives received by the Co	View
Payable to employees due to the exercise	View
Other payables and accruals	View	View	View	View
Total Current Liabilities	View	View	View	View
Advanced Subsidies	View
Total Liabilities	View	View	View	View
Convertible Preferred Shares			View	View
Ordinary Shares	View	View	View	View
Additional Paid in Capital	View	View	View	View
Statutory Reserves	View	View	View	View
Retained Earnings	View	View	View	View
Accumulated Other Comprehensive Income	View	View	View	View
Treasury Stock	View
Total Equity	View	View	View	View
Total Liabilities & Shareholders' Equity	View	View	View	View

Cash Flow Statement	2011	2010	2009	2008	2007
Net Income (Loss)	View	View	View	View	View
Depreciation	View	View	View	View	View
Amortization of Land Use Rights	View	View	View
Bad Debt Provision	View	View	View	View
Inventory Provision	View	View	View	View	View
Gain from investment securities		View
Impairment in Value of Investment Sec.			View
Gain from disposal of fixed assets	View	View
Loss Related to Derivatives	View	View	View	View
Deferred Tax	View	View	View	View
Share-based Compensation Expense	View	View	View	View
Inc. in Accounts Receivable	View	View	View	View	View
Inc. in Inventories	View	View	View	View	View
Increase in amounts due from related par	View			View	View
Increase in other long-term assets	View	View
Inc. in Prepayments & Other Current Assets	View	View	View	View	View
Inc./Dec. in Accounts Payable	View	View	View	View	View
Inc./Dec. in Amt. due to Related Parties	View	View	View	View	View
Inc. in Salary & Welfare Payable	View	View	View	View	View
Inc./Dec. in Income Taxes Payable	View	View	View	View	View
Increase in advanced subsidies	View
Inc./Dec. in Advance from Customers	View	View	View	View	View
Inc./Dec. in Other Payables & Accruals	View	View	View	View	View
Cash from Operating Activities	View	View	View	View	View
Proceeds from repayment of loan due from				View
Purchase of Property, Equipment & SW	View	View	View	View	View
Proceeds from disposal of investment sec	View	View
Proceeds from disposal of fixed assets	View	View
Purchase of Land Use Right	View		View
Payment for Investment in Securities			View	View	View
Payment for Settlement of Derivatives	View	View	View
Inc./Dec. in Restricted Cash	View	View	View	View	View
Cash from Investing Activities	View	View	View	View	View
Repurchase of ordinary shares	View
Proceeds from issuance of ordinary share	View
Cash proceeds from initial public offering	View	View
Repayment of short-term bank borrowings	View	View
Proceeds from short-term bank borrowings		View
Proceeds from Issue of Preferred Shares					View
Dividends Paid					View
Cash from Financing Activities	View	View			View
Foreign Exchange Effects	View	View	View	View	View
Total Cash Flow (Net Change in Cash)	View	View	View	View	View
Cash & Cash Equivalents Beginning of Year	View	View	View	View	View
Cash & Cash Equivalents End of Year	View	View	View	View	View

Financial Notes:
*	ShangPharma Corp fiscal year end: 12/31

	Date	Status	Target	Buyer	Deal Type	Price
Details	Dec. 2012	Completed	View¹	View	Acquisition Leveraged Buyout (LBO) Take Private	View

1	CEO of ShangPharma, Michael Xin...Read More →
	Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

	Date	Deal Type	Action	Resulting Status	Valuation	Amount Raised	Public Ticker
Details	Dec. 2012	View	View	View¹	View	View	View

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

ShangPharma Corp

Business Summary

Overview & Corporate Organization

Basic Information

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Ownership

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

ShangPharma Corp Revenues ($ MM): (Displayed as graph)

ShangPharma Corp COR-Unrelated Parties ($ MM): (Displayed as graph)

ShangPharma Corp COR-Related Parties ($ MM): (Displayed as graph)

ShangPharma Corp Selling & Marketing ($ MM): (Displayed as graph)

ShangPharma Corp General & Administrative ($ MM): (Displayed as graph)

ShangPharma Corp Total Operating Expense ($ MM): (Displayed as graph)

ShangPharma Corp Interest expense ($): (Displayed as graph)

ShangPharma Corp Interest Income ($): (Displayed as graph)

ShangPharma Corp Other Income ($ MM): (Displayed as graph)

ShangPharma Corp Other Expenses ($ MM): (Displayed as graph)

ShangPharma Corp Net Income Before Taxes ($ MM): (Displayed as graph)

ShangPharma Corp Provision for Income Taxes ($ MM): (Displayed as graph)

ShangPharma Corp Net Income (Loss) ($ MM): (Displayed as graph)

ShangPharma Corp Cash and cash equivalents ($ MM): (Displayed as graph)

ShangPharma Corp Restricted cash ($ MM): (Displayed as graph)

ShangPharma Corp Accounts Receivables ($ MM): (Displayed as graph)

ShangPharma Corp Allowance for Doubtful Accounts ($): (Displayed as graph)

ShangPharma Corp Raw Materials ($): (Displayed as graph)

ShangPharma Corp Work in Progress ($ MM): (Displayed as graph)

ShangPharma Corp Finished Goods ($): (Displayed as graph)

ShangPharma Corp Prepaid Rental & Deposit ($ MM): (Displayed as graph)

ShangPharma Corp Deposit to be Refunded for Purchase LR ($): (Displayed as graph)

ShangPharma Corp Prepayments for Purchase of RM ($): (Displayed as graph)

ShangPharma Corp Prepayment for D&O insurance ($): (Displayed as graph)

ShangPharma Corp Derivative assets ($ MM): (Displayed as graph)

ShangPharma Corp Others ($): (Displayed as graph)

ShangPharma Corp Deferred Tax Assets ($): (Displayed as graph)

ShangPharma Corp Total Current Assets ($ MM): (Displayed as graph)

ShangPharma Corp Leasehold Improvements ($ MM): (Displayed as graph)

ShangPharma Corp Experimental Equipment ($ MM): (Displayed as graph)

ShangPharma Corp Vehicles ($): (Displayed as graph)

ShangPharma Corp Office Equipment & Others ($ MM): (Displayed as graph)

ShangPharma Corp Buildings and constructions ($ MM): (Displayed as graph)

ShangPharma Corp Software Licenses ($ MM): (Displayed as graph)

ShangPharma Corp Construction in Progress ($ MM): (Displayed as graph)

ShangPharma Corp Accumulated Depreciation & Amortization ($ MM): (Displayed as graph)

ShangPharma Corp Derivative assets ($): (Displayed as graph)

ShangPharma Corp Land Use Right ($ MM): (Displayed as graph)

ShangPharma Corp Accumulated amortization ($): (Displayed as graph)

ShangPharma Corp Other long-term assets ($): (Displayed as graph)

ShangPharma Corp Total Assets ($ MM): (Displayed as graph)

ShangPharma Corp Accounts Payable ($ MM): (Displayed as graph)

ShangPharma Corp Amounts Due to Related Parties ($ MM): (Displayed as graph)

ShangPharma Corp Salary & Welfare Payable ($ MM): (Displayed as graph)

ShangPharma Corp Income Taxes Payable ($ MM): (Displayed as graph)

ShangPharma Corp Advance from Customers ($ MM): (Displayed as graph)

ShangPharma Corp Value Added Tax & Other Taxes Payable ($ MM): (Displayed as graph)

ShangPharma Corp Accrued Rental & Utilities ($): (Displayed as graph)

ShangPharma Corp Derivative Liability ($): (Displayed as graph)

ShangPharma Corp Accrued Consulting & Audit Fee ($): (Displayed as graph)

ShangPharma Corp Unearned Government Subsidies ($): (Displayed as graph)

ShangPharma Corp Accrued Employee Annual Leave ($): (Displayed as graph)

ShangPharma Corp Other payables and accruals ($): (Displayed as graph)

ShangPharma Corp Total Current Liabilities ($ MM): (Displayed as graph)

ShangPharma Corp Total Liabilities ($ MM): (Displayed as graph)

ShangPharma Corp Convertible Preferred Shares ($ MM): (Displayed as graph)

ShangPharma Corp Ordinary Shares ($): (Displayed as graph)

ShangPharma Corp Additional Paid in Capital ($ MM): (Displayed as graph)

ShangPharma Corp Statutory Reserves ($ MM): (Displayed as graph)

ShangPharma Corp Retained Earnings ($ MM): (Displayed as graph)

ShangPharma Corp Accumulated Other Comprehensive Income ($ MM): (Displayed as graph)

ShangPharma Corp Total Equity ($ MM): (Displayed as graph)

ShangPharma Corp Total Liabilities & Shareholders' Equity ($ MM): (Displayed as graph)

ShangPharma Corp Net Income (Loss) ($ MM): (Displayed as graph)

ShangPharma Corp Depreciation ($ MM): (Displayed as graph)

ShangPharma Corp Amortization of Land Use Rights ($): (Displayed as graph)

ShangPharma Corp Bad Debt Provision ($): (Displayed as graph)

ShangPharma Corp Inventory Provision ($): (Displayed as graph)

ShangPharma Corp Gain from disposal of fixed assets ($): (Displayed as graph)

ShangPharma Corp Loss Related to Derivatives ($ MM): (Displayed as graph)

ShangPharma Corp Revenues ($ MM):
(Displayed as graph)

ShangPharma Corp COR-Unrelated Parties ($ MM):
(Displayed as graph)

ShangPharma Corp COR-Related Parties ($ MM):
(Displayed as graph)

ShangPharma Corp Selling & Marketing ($ MM):
(Displayed as graph)

ShangPharma Corp General & Administrative ($ MM):
(Displayed as graph)

ShangPharma Corp Total Operating Expense ($ MM):
(Displayed as graph)

ShangPharma Corp Interest expense ($):
(Displayed as graph)

ShangPharma Corp Interest Income ($):
(Displayed as graph)

ShangPharma Corp Other Income ($ MM):
(Displayed as graph)

ShangPharma Corp Other Expenses ($ MM):
(Displayed as graph)

ShangPharma Corp Net Income Before Taxes ($ MM):
(Displayed as graph)

ShangPharma Corp Provision for Income Taxes ($ MM):
(Displayed as graph)

ShangPharma Corp Net Income (Loss) ($ MM):
(Displayed as graph)

ShangPharma Corp Cash and cash equivalents ($ MM):
(Displayed as graph)

ShangPharma Corp Restricted cash ($ MM):
(Displayed as graph)

ShangPharma Corp Accounts Receivables ($ MM):
(Displayed as graph)

ShangPharma Corp Allowance for Doubtful Accounts ($):
(Displayed as graph)

ShangPharma Corp Raw Materials ($):
(Displayed as graph)

ShangPharma Corp Work in Progress ($ MM):
(Displayed as graph)

ShangPharma Corp Finished Goods ($):
(Displayed as graph)

ShangPharma Corp Prepaid Rental & Deposit ($ MM):
(Displayed as graph)

ShangPharma Corp Deposit to be Refunded for Purchase LR ($):
(Displayed as graph)

ShangPharma Corp Prepayments for Purchase of RM ($):
(Displayed as graph)

ShangPharma Corp Prepayment for D&O insurance ($):
(Displayed as graph)

ShangPharma Corp Derivative assets ($ MM):
(Displayed as graph)

ShangPharma Corp Others ($):
(Displayed as graph)

ShangPharma Corp Deferred Tax Assets ($):
(Displayed as graph)

ShangPharma Corp Total Current Assets ($ MM):
(Displayed as graph)

ShangPharma Corp Leasehold Improvements ($ MM):
(Displayed as graph)

ShangPharma Corp Experimental Equipment ($ MM):
(Displayed as graph)

ShangPharma Corp Vehicles ($):
(Displayed as graph)

ShangPharma Corp Office Equipment & Others ($ MM):
(Displayed as graph)

ShangPharma Corp Buildings and constructions ($ MM):
(Displayed as graph)

ShangPharma Corp Software Licenses ($ MM):
(Displayed as graph)

ShangPharma Corp Construction in Progress ($ MM):
(Displayed as graph)

ShangPharma Corp Accumulated Depreciation & Amortization ($ MM):
(Displayed as graph)

ShangPharma Corp Derivative assets ($):
(Displayed as graph)

ShangPharma Corp Land Use Right ($ MM):
(Displayed as graph)

ShangPharma Corp Accumulated amortization ($):
(Displayed as graph)

ShangPharma Corp Other long-term assets ($):
(Displayed as graph)

ShangPharma Corp Total Assets ($ MM):
(Displayed as graph)

ShangPharma Corp Accounts Payable ($ MM):
(Displayed as graph)

ShangPharma Corp Amounts Due to Related Parties ($ MM):
(Displayed as graph)

ShangPharma Corp Salary & Welfare Payable ($ MM):
(Displayed as graph)

ShangPharma Corp Income Taxes Payable ($ MM):
(Displayed as graph)

ShangPharma Corp Advance from Customers ($ MM):
(Displayed as graph)

ShangPharma Corp Value Added Tax & Other Taxes Payable ($ MM):
(Displayed as graph)

ShangPharma Corp Accrued Rental & Utilities ($):
(Displayed as graph)

ShangPharma Corp Derivative Liability ($):
(Displayed as graph)

ShangPharma Corp Accrued Consulting & Audit Fee ($):
(Displayed as graph)

ShangPharma Corp Unearned Government Subsidies ($):
(Displayed as graph)

ShangPharma Corp Accrued Employee Annual Leave ($):
(Displayed as graph)

ShangPharma Corp Other payables and accruals ($):
(Displayed as graph)

ShangPharma Corp Total Current Liabilities ($ MM):
(Displayed as graph)

ShangPharma Corp Total Liabilities ($ MM):
(Displayed as graph)

ShangPharma Corp Convertible Preferred Shares ($ MM):
(Displayed as graph)

ShangPharma Corp Ordinary Shares ($):
(Displayed as graph)

ShangPharma Corp Additional Paid in Capital ($ MM):
(Displayed as graph)

ShangPharma Corp Statutory Reserves ($ MM):
(Displayed as graph)

ShangPharma Corp Retained Earnings ($ MM):
(Displayed as graph)

ShangPharma Corp Accumulated Other Comprehensive Income ($ MM):
(Displayed as graph)

ShangPharma Corp Total Equity ($ MM):
(Displayed as graph)

ShangPharma Corp Total Liabilities & Shareholders' Equity ($ MM):
(Displayed as graph)

ShangPharma Corp Net Income (Loss) ($ MM):
(Displayed as graph)

ShangPharma Corp Depreciation ($ MM):
(Displayed as graph)

ShangPharma Corp Amortization of Land Use Rights ($):
(Displayed as graph)

ShangPharma Corp Bad Debt Provision ($):
(Displayed as graph)

ShangPharma Corp Inventory Provision ($):
(Displayed as graph)

ShangPharma Corp Gain from disposal of fixed assets ($):
(Displayed as graph)

ShangPharma Corp Loss Related to Derivatives ($ MM):
(Displayed as graph)

ShangPharma Corp Deferred Tax ($):
(Displayed as graph)

ShangPharma Corp Share-based Compensation Expense ($ MM):
(Displayed as graph)

ShangPharma Corp Inc. in Accounts Receivable ($ MM):
(Displayed as graph)

ShangPharma Corp Inc. in Inventories ($ MM):
(Displayed as graph)

ShangPharma Corp Increase in amounts due from related par ($):
(Displayed as graph)

ShangPharma Corp Increase in other long-term assets ($):
(Displayed as graph)

ShangPharma Corp Inc. in Prepayments & Other Current Assets ($ MM):
(Displayed as graph)

ShangPharma Corp Inc./Dec. in Accounts Payable ($ MM):
(Displayed as graph)

ShangPharma Corp Inc./Dec. in Amt. due to Related Parties ($ MM):
(Displayed as graph)

ShangPharma Corp Inc. in Salary & Welfare Payable ($ MM):
(Displayed as graph)